BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 33495318)

  • 1. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission.
    De Gregorio D; Popic J; Enns JP; Inserra A; Skalecka A; Markopoulos A; Posa L; Lopez-Canul M; Qianzi H; Lafferty CK; Britt JP; Comai S; Aguilar-Valles A; Sonenberg N; Gobbi G
    Proc Natl Acad Sci U S A; 2021 Feb; 118(5):. PubMed ID: 33495318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex.
    Arvanov VL; Liang X; Russo A; Wang RY
    Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin suppresses basal glutamatergic transmission but facilitates activity-dependent synaptic potentiation in the medial prefrontal cortex.
    Ninan I
    J Neurochem; 2011 Oct; 119(2):324-31. PubMed ID: 21848811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling.
    Buchborn T; Schröder H; Höllt V; Grecksch G
    J Psychopharmacol; 2014 Jun; 28(6):545-52. PubMed ID: 24785760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline.
    De Gregorio D; Inserra A; Enns JP; Markopoulos A; Pileggi M; El Rahimy Y; Lopez-Canul M; Comai S; Gobbi G
    Neuropsychopharmacology; 2022 May; 47(6):1188-1198. PubMed ID: 35301424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-HT
    Fukumoto K; Iijima M; Funakoshi T; Chaki S
    Neuropharmacology; 2018 Jul; 137():96-103. PubMed ID: 29738849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IQSEC2 Deficiency Results in Abnormal Social Behaviors Relevant to Autism by Affecting Functions of Neural Circuits in the Medial Prefrontal Cortex.
    Mehta A; Shirai Y; Kouyama-Suzuki E; Zhou M; Yoshizawa T; Yanagawa T; Mori T; Tabuchi K
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRK5 Regulates Social Behavior Via Suppression of mTORC1 Signaling in Medial Prefrontal Cortex.
    Niu B; Liu P; Shen M; Liu C; Wang L; Wang F; Ma L
    Cereb Cortex; 2018 Feb; 28(2):421-432. PubMed ID: 28334166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NMDA and AMPA/kainate glutamatergic receptors in the prelimbic medial prefrontal cortex modulate the elaborated defensive behavior and innate fear-induced antinociception elicited by GABAA receptor blockade in the medial hypothalamus.
    de Freitas RL; Salgado-Rohner CJ; Biagioni AF; Medeiros P; Hallak JE; Crippa JA; Coimbra NC
    Cereb Cortex; 2014 Jun; 24(6):1518-28. PubMed ID: 23349224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of α₁-adrenoceptors enhances excitatory synaptic transmission via a pre- and postsynaptic protein kinase C-dependent mechanism in the medial prefrontal cortex of rats.
    Luo F; Tang H; Li BM; Li SH
    Eur J Neurosci; 2014 Apr; 39(8):1281-93. PubMed ID: 24494713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration.
    Nichols CD; Garcia EE; Sanders-Bush E
    Brain Res Mol Brain Res; 2003 Mar; 111(1-2):182-8. PubMed ID: 12654518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex.
    Labonte B; Bambico FR; Gobbi G
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Nov; 380(5):383-97. PubMed ID: 19727675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology.
    De Gregorio D; Comai S; Posa L; Gobbi G
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27886063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic enhancement of excitatory synaptic transmission in layer II entorhinal neurons is dependent on D₁-like receptor-mediated signaling.
    Glovaci I; Caruana DA; Chapman CA
    Neuroscience; 2014 Jan; 258():74-83. PubMed ID: 24220689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional Homeostatic Regulation of a Depression-Related Brain State by Gamma-Aminobutyric Acidergic Deficits and Ketamine Treatment.
    Ren Z; Pribiag H; Jefferson SJ; Shorey M; Fuchs T; Stellwagen D; Luscher B
    Biol Psychiatry; 2016 Sep; 80(6):457-468. PubMed ID: 27062563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex.
    Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E
    Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice.
    Tang J; Xue W; Xia B; Ren L; Tao W; Chen C; Zhang H; Wu R; Wang Q; Wu H; Duan J; Chen G
    Sci Rep; 2015 Aug; 5():13573. PubMed ID: 26315757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and biotransformation studies of 1-acyl-substituted derivatives of d-lysergic acid diethylamide (LSD).
    Halberstadt AL; Chatha M; Klein AK; McCorvy JD; Meyer MR; Wagmann L; Stratford A; Brandt SD
    Neuropharmacology; 2020 Aug; 172():107856. PubMed ID: 31756337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipsychotic drugs reverse the AMPA receptor-stimulated release of 5-HT in the medial prefrontal cortex.
    Amargós-Bosch M; Adell A; Artigas F
    J Neurochem; 2007 Jul; 102(2):550-61. PubMed ID: 17394545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.